BAC

Bank of America
D

BAC

Arincen57/100B
51.620
USD
1.96
(3.95%)
Post Trading·51.640USD+0.020(+0.04%)
Last updated: · Delayed 15 min
Fair value53.26Plus-3%31Price 51.6273
Q4 FY2026 · Earnings report
EPS estimate 1.13Revenue estimate 30.48B
OverviewFinancialsSignalsNewsForecastEarningsDividendsCompany

Bank of America executives and insider trading

Brian Thomas Moynihan reported no open-market purchases or sales over the last twelve months.

Over the last twelve months Bank of America's insiders sold 619,146 shares for 31.08M USD in 7 sales on the open market, and bought 0 shares in 0 purchases.

Insiders over the last twelve months

Insider sales
7
Shares sold
619,146
Value sold
31.08M USD
Insider purchases
0

Insiders buying against selling

Bought on the market
Sold on the market
0
1 week
0
0
1 month
0
0
3 months
0
0
6 months
0
0
1 year
31.08M USD
0
2 years
37.84M USD
Sold, decided at the timeSold under a Rule 10b5-1 plan set in advance

Open-market purchases and sales reported on Form 4, by value. Awards, option exercises and shares withheld for tax are not counted. Whether a sale was under a Rule 10b5-1 plan is read from each Form 4 at the SEC (the box exists on filings since April 2023).

Executives and directors

The people who run the company and the directors who reported trades, with what each bought and sold on the open market over the last twelve months. The CEO first, then whoever traded most.

NamePositionAgeShares sold (12 months)Value sold (12 months)Shares bought (12 months)Last saleShares held after
Dean C. Athanasia Co-President59136,5586.86M USD—3 Mar 2026558,541
Geoffrey S Greener Chief Risk Officer—126,7566.72M USD—5 May 20261,373,397
Bernard A Mensah President, International—94,0004.41M USD—12 Mar 2026170,184
James DeMare Co-President5683,8324.19M USD—4 Mar 2026307,240
Alastair Borthwick Executive Vice President & Chief Financial Officer5768,0003.42M USD—27 Feb 2026406,944
Sheri B. Bronstein Chief People Officer—60,0002.99M USD—5 Mar 2026335,690
Thomas Scrivener Chief Operations Executive5450,0002.49M USD—5 Mar 2026227,973

Insider sales and purchases by quarter

How many insider sales and purchases were reported each quarter.

Insider sales Insider purchases

Every insider transaction

Insiders must report every trade in the company's shares to the SEC within two business days, on Form 4. Only purchases and sales are trades on the open market; awards, option exercises, shares withheld for tax and gifts come with pay, and the twelve-month totals leave them out.

DateNameTransactionSharesPriceValueShares held afterFiling
5 May 2026Geoffrey S GreenerSale126,75653.016.72M USD1,373,397Form 4
12 Mar 2026Bernard A MensahSale94,00046.944.41M USD170,184Form 4
5 Mar 2026Thomas ScrivenerSale50,00049.822.49M USD227,973Form 4
5 Mar 2026Sheri B. BronsteinSale60,00049.912.99M USD335,690Form 4
4 Mar 2026James DeMareSale83,83250.004.19M USD307,240Form 4
3 Mar 2026Dean C. AthanasiaSale136,55850.216.86M USD558,541Form 4
27 Feb 2026Alastair BorthwickSale68,00050.243.42M USD327,843Form 4
1 Aug 2025James DeMareSale148,39145.576.76M USD223,407Form 4

Common questions about Bank of America's executives and insiders

Source: Financial Modeling Prep

Smarter Decisions,Together
FacebookTwitterYoutubeInstagramLinkedIn
App Store
iOS
Google Play
Android

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.